VTAE Overview
Upcoming Projects (VTAE)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (VTAE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (VTAE)
-
Vitae plans to advance VTP-43742 into a 16-week Phase 2 trial in the fourth quarter of 2016 - Discontinued
Ticker: VTAE
Occurred on: Oct 25, 2016 -
Allergan (AGN) Adds to Dermatology Programs in Agreement to Acquire Vitae Pharmaceuticals (VTAE) for ~$639 Million
Tickers: AGN, VTAE
Occurred on: Sep 14, 2016 -
Vitae Pharmaceuticals(VTAE) to complete phase 1 and 2 studies on VTP-43742 in March 2016
Ticker: VTAE
Occurred on: Mar 16, 2016 -
Vitae expects to report top-line data from Phase 2 clinical trial of VTP-43742 in psoriasis patients in the second half of 2017
Ticker: VTAE
Occurred on: Mar 16, 2016 -
Vitae Pharmaceuticals(VTAE) expects to initiate a phase 1 clinical trial for VTP-38543 in Atopic Dermatitus in the second half of 2015
Ticker: VTAE
Occurred on: Dec 10, 2015 -
Vitae Pharmaceuticals to Host Analyst and Investor Briefing
Ticker: VTAE
Occurred on: Nov 19, 2015
Strategic Initiatives (VTAE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
